1874 Phase 1b/2 study results for masitinib plus gemcitabine and carboplatin in advanced triple negative breast cancer. (September 2015) - Campone, M.; Ferrero, J.M.; Gunzer, K.; Priou, F.; Dubreuil, P.; Mansfield, C.; Moussy, A.; Hermine, O.